| P50 | author | Maurizio Fava | Q30089873 |
| | Madhukar Trivedi | Q87600331 |
| | Michael E Thase | Q91359309 |
| P2093 | author name string | Ying Qi | |
| | Jian Han | |
| | J Craig Nelson | |
| | Andrei Pikalov | |
| | Robert M Berman | |
| | Ronald N Marcus | |
| | Berit X Carlson | |
| | Quynh Van Tran | |
| P2860 | cites work | A rating scale for drug-induced akathisia | Q28258433 |
| | A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder | Q28291261 |
| | A New Depression Scale Designed to be Sensitive to Change | Q29614720 |
| | The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor | Q33959664 |
| | Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. | Q33966353 |
| | Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review | Q33988376 |
| | The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study. | Q34004814 |
| | SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. | Q34067137 |
| | Consensus development conference on antipsychotic drugs and obesity and diabetes | Q34293049 |
| | Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation | Q34568196 |
| | Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic | Q35094691 |
| | Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice. | Q36459131 |
| | Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review | Q37111491 |
| | Selective serotonin-reuptake inhibitor-induced movement disorders | Q42541451 |
| | Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance. | Q42672203 |
| | RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ). | Q43273547 |
| | Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors | Q44028935 |
| | Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. | Q44167467 |
| | Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials | Q44428863 |
| | A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 |
| | The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study | Q44627462 |
| | Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia | Q44649979 |
| | Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study. | Q44662788 |
| | In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function | Q44716841 |
| | Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study | Q46669710 |
| | Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study | Q46886132 |
| | Adjunctive aripiprazole in treatment-resistant bipolar depression. | Q51789886 |
| | Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association | Q73682867 |
| P433 | issue | 6 | |
| P921 | main subject | major depressive disorder | Q42844 |
| P304 | page(s) | 344-352 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Primary Care Companion to the Journal of Clinical Psychiatry | Q15751574 |
| P1476 | title | Safety and Tolerability of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Post Hoc Analysis (studies CN138-139 and CN138-163). | |
| P478 | volume | 11 | |